Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
278 SEK | 0.00% |
|
+0.73% | +11.67% |
Jun. 17 | Global markets live: AstraZeneca, Apple, Meta, Microsoft, Cisco... | ![]() |
Jun. 17 | Sweden’s Essity Targets 3% Annual Organic Sales Growth | MT |
Strengths
- Analyst opinion has improved significantly over the past four months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
Ratings chart - Surperformance
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+11.67% | 18.44B | - | ||
+13.62% | 388B | C- | ||
+22.83% | 79.79B | A+ | ||
+0.99% | 73.63B | A- | ||
-30.40% | 36.23B | B+ | ||
-16.00% | 34.68B | - | ||
+0.04% | 33.31B | B- | ||
+28.43% | 17.58B | B | ||
+15.03% | 13.41B | C+ | ||
+23.57% | 10.09B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- ESSITY B Stock
- ESSITY A Stock
- Ratings Essity AB